Cabazitaxel is a type of chemotherapy drug. It is meant for treating advanced prostate cancer that is no longer responding to hormone therapy.
CGHS Medical Store Department, Directorate General of Central Government Health Scheme has issued an instruction regarding supply of Cabazitaxel to CGHS Benfeciaries.
It is instructed that Cabazitaxel can be issued to CGHS beneficiaries suffering from Carcinoma Prostate as a second line therapy only in “Docetaxel Resistant cases”.
Full text of this Office Memorandum dated 03.09.2012 is as follows.
GOVERNMENT OF INDIA
DIRECTORATE GENERAL OF CENTRAL GOVERNMENT HEALTH SCHEME
CGHS MEDICAL STORE DEPOT
SEC. 11 UDYAN MARG, DIZ AREA, GOLE MARKET
NEW DELHI – 110001
Subject : Issue of Inj. CABAZITAXEL for CGHS BENEFICIARIES.
The undersigned is directed to refer to the subject mentioned above and to state that Inj. CABAZITAXEL is being issued to CGHS beneficiaries for treatment of Carcinoma Prostate through Medical Store Depot, Gole Market, New Delhi.
Now the matter has been examined by committee of experts and it is decided that Inj. Cabazitaxel can be issued to CGHS beneficiaries suffering from Carcinoma Prostate as a second line therapy only in “Docetaxel Resistant cases”. It can be prescribed by Medical Oncologist, Urologist and Radiotherapist only.